Proton therapy and concurrent chemotherapy may reduce bone marrow toxicity in advanced lung cancer
Thursday, November 13, 2008 - 15:28
in Health & Medicine
Patients treated for locally advanced non-small cell lung cancer who receive chemotherapy and proton beam therapy have fewer instances of bone marrow toxicity than patients who receive the standard treatment of intensity-modulated radiation (IMRT) and concurrent chemotherapy, according to researchers from The University of Texas M. D. Anderson Cancer Center.
Read the whole article on Physorg
More from Physorg
Related
- Proton therapy and concurrent chemotherapy may reduce bone marrow toxicity in advanced lung cancerThu, 13 Nov 2008, 15:22:04 EST
- Proton therapy may reduce serious side effect of lung cancer treatmentThu, 13 Nov 2008, 10:51:08 EST
- Vandetanib shows clinical benefit when combined with docetaxel for lung cancerMon, 1 Jun 2009, 9:44:28 EDT
- Study of concurrent radiotherapy, chemotherapy shows promise in small cell lung cancerWed, 4 Nov 2009, 1:34:09 EST
- Iressa proves just as effective as chemotherapy for lung cancerThu, 20 Nov 2008, 19:32:03 EST